Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

Background: Previous studies in patients with osteoarthritis have suggested that the selective cyclooxygenase (COX)-2 inhibitor rofecoxib results in less gastrointestinal damage than non-selective non-steroidal antiinflammatory drugs (NSAIDs). This study compared the incidence of endoscopically dete...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hawkey, C J, Laine, L, Simon, T, Quan, H, Shingo, S, Evans, J
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2003
Matèries:
Stomach
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773685/
https://ncbi.nlm.nih.gov/pubmed/12740337
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars